Agilent acquires genomics software provider

Skip to Navigation

News

  • Published: May 6, 2015
  • Author: Jon Evans
  • Source: Agilent Technologies
  • Suppliers: Agilent Technologies
  • Channels: Proteomics & Genomics / Electrophoresis

Agilent Technologies has announced its acquisition of Cartagenia, a US provider of software and services for clinical genetics and molecular pathology labs.

Cartagenia provides software solutions for variant assessment and reporting of clinical genomics data from next-generation sequencing and microarrays, including electrophoresis-based microarrays. Marketed as the Bench suite, these software solutions allow technicians, lab directors and clinicians to visualize, assess and report clinical genetics data in the context of patient information.

With Cartagenia Bench, labs can build an internal knowledge base, build variant assessment SOPs, automate report drafting and access a wide range of community-validated, private and premium content resources, whether for oncology or inherited disease. Cartagenia’s platform also provides deep support for consortia of collaborating labs, allowing users to connect and pool their knowledge on rare diseases and actionable findings.

‘Cartagenia’s approach to enabling the interpretation of clinical genomics data is revolutionary,’ said Jacob Thaysen, president of Agilent’s diagnostics and genomics group. ‘We look forward to providing Cartagenia’s software solutions to our clinical genetics and molecular oncology customers and to providing Cartagenia’s existing customers with access to our global service and support network. Together, Agilent and Cartagenia can help remove bottlenecks inherent in analysis, interpretation and reporting clinical data – resulting in faster answers for patients.’

‘Joining forces with Agilent is an excellent strategic fit and provides tremendous opportunity both for our customers – who will benefit from integration with a broad family of solutions and a range of new applications – and for our team, as we’ll be able to further accelerate our success and growth through Agilent’s global reach and leading footprint in clinical labs,’ said Herman Verrelst, chief executive officer of Cartagenia.

The acquisition is expected to be completed by 19 May, subject to local laws and regulations and customary closing conditions. Cartagenia employs 36 people, all of whom will be offered employment with Agilent. Financial terms of the transaction were not disclosed.

Social Links

Share This Links

Bookmark and Share

Microsites

Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in separation science? Visit our sister site separationsNOW.com

Copyright © 2017 John Wiley & Sons, Inc. All Rights Reserved